Characteristics of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Anticentriole Autoantibodies

被引:5
作者
Maki, Hisataka [1 ]
Kubota, Kana [1 ,2 ]
Hatano, Masaru [1 ,4 ]
Minatsuki, Shun [1 ]
Amiya, Eisuke [1 ,4 ]
Yoshizaki, Ayumi [3 ]
Asano, Yoshihide [3 ]
Morita, Hiroyuki [1 ]
Sato, Shinichi [3 ]
Komuro, Issei [1 ]
机构
[1] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan
[2] Jichi Med Univ, Dept Internal Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo, Japan
[4] Univ Tokyo, Grad Sch Med, Therapeut Strategy Heart Failure, Tokyo, Japan
关键词
Elderly; COMBINATION THERAPY; SCLERODERMA; CENTRIOLE; ANTIBODIES;
D O I
10.1536/ihj.19-659
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anticentriole autoantibodies-positive systemic sclerosis (SSc) has been reported to develop pulmonary arterial hypertension (PAH) at a high rate. In this report, we describe two patients with anticentriole antibodiespositive SSc-PAH who were treated with pulmonary vasodilators. Both cases were elderly women with poor physical conditions and clinical findings of SSc. Case 1 was resistant to combination therapy with pulmonary vasodilators; in Case 2, hemodynamic improvement was obtained by upfront combination therapy at an early stage. Because anticentriole antibodies-positive SSc-PAH rapidly deteriorates, careful hemodynamic observation and timely aggressive use of pulmonary vasodilators should be considered.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 14 条
[1]  
BRENNER S, 1980, J CELL BIOL, V87, pA24
[2]   Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study [J].
Hachulla, E ;
Gressin, V ;
Guillevin, L ;
Carpentier, P ;
Diot, E ;
Sibilia, J ;
Kahan, A ;
Cabane, J ;
Francès, C ;
Launay, D ;
Mouthon, L ;
Allanore, Y ;
Tiev, KP ;
Clerson, P ;
de Groote, P ;
Humbert, M .
ARTHRITIS AND RHEUMATISM, 2005, 52 (12) :3792-3800
[3]   High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies [J].
Hamaguchi, Yasuhito ;
Matsushita, Takashi ;
Hasegawa, Minoru ;
Ueda-Hayakawa, Ikuko ;
Sato, Sinichi ;
Takehara, Kazuhiko ;
Fujimoto, Manabu .
MODERN RHEUMATOLOGY, 2015, 25 (05) :798-801
[4]   Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension [J].
Hassoun, Paul M. ;
Zamanian, Roham T. ;
Damico, Rachel ;
Lechtzin, Noah ;
Khair, Rubina ;
Kolb, Todd M. ;
Tedford, Ryan J. ;
Hulme, Olivia L. ;
Housten, Traci ;
Pisanello, Chiara ;
Sato, Takahiro ;
Pullins, Erica H. ;
Corona-Villalobos, Celia P. ;
Zimmerman, Stefan L. ;
Gashouta, Mohamed A. ;
Minai, Omar A. ;
Torres, Fernando ;
Girgis, Reda E. ;
Chin, Kelly ;
Mathai, Stephen C. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (09) :1102-1110
[5]   HUMAN ANTICENTRIOLE AUTOANTIBODY IN PATIENTS WITH SCLERODERMA AND RAYNAUDS-PHENOMENON [J].
MOROI, Y ;
MURATA, I ;
TAKEUCHI, A ;
KAMATANI, N ;
TANIMOTO, K ;
YOKOHARI, R .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 29 (03) :381-390
[6]   Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach [J].
Mukerjee, D ;
St George, D ;
Coleiro, B ;
Knight, C ;
Denton, CP ;
Davar, J ;
Black, CM ;
Coghlan, JG .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (11) :1088-1093
[7]   ANTICENTRIOLE ANTIBODY IN A PATIENT WITH PROGRESSIVE SYSTEMIC-SCLEROSIS [J].
OSBORN, TG ;
RYERSE, JS ;
BAUER, NE ;
URHAHN, JM ;
BLAIR, D ;
MOORE, TL .
ARTHRITIS AND RHEUMATISM, 1986, 29 (01) :142-146
[8]  
OSBORN TG, 1982, NEW ENGL J MED, V307, P253
[9]   Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy [J].
Overbeek, M. J. ;
Vonk, M. C. ;
Boonstra, A. ;
Voskuyl, A. E. ;
Vonk-Noordegraaf, A. ;
Smit, E. F. ;
Dijkmans, B. A. C. ;
Postmus, P. E. ;
Mooi, W. J. ;
Heijdra, Y. ;
Gruenberg, K. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (02) :371-379
[10]  
RATTNER JB, 1991, J IMMUNOL, V146, P2341